Cat Allergy in Humans Market (Treatment: Antihistamines, Corticosteroid Nasal Sprays, Decongestants, Leukotriene Inhibitors, and Others; Application; Allergy Treatment and Allergy Prevention) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

According to Nova one advisor, the global Cat Allergy in Humans market was valued at USD 5.2 billion in 2021 and it is expected to hit around USD 10.8 billion by 2030 with a CAGR of 7.3% during the forecast period 2022 to 2030.

When people are exposed to various pets, such as dogs and cats, they develop a variety of allergies. The most common types of allergies are runny nose, sneezing, nasal congestion, itchy eyes, as well as skin rash. Allergies to cat is a human allergic reaction to allergens produced by cats. Cat allergens of the most common types are Fel d1 (secreted by the cat's sebaceous glands) and Fel d4 (found in the cat's saliva). pet allergy affects nearly 25% of allergic patients due to Fel d1 and Fel d4 proteins. Cat allergens, particularly Fel d1, are abundant in the form of dander and are thought to be a major cause of allergic asthma around the world. The primary treatment for allergic patients is to avoid cats. Certain allergy Treatment and allergy shots, on the other hand, can help control the symptoms of cat allergies.

Report Scope of the Cat Allergy in Humans Market

Allergy-causing Genetic Traits to Contribute to Prevalence Rate of Allergy

An article published by Allergy U.K. stated that children born into families with a history of allergies are more likely to develop allergies as compared to other children. Increase in tendency of families and children to develop allergies due to their genetic links is known as ‘being atopic’. Researchers have estimated that half of the children from atopic families are likely to have allergies themselves. However, this rate in children from non-atopic families is 1 in 5 children who may go on to have an allergy.

Along with lifestyle changes, changing climate with increased pollution, CO2 levels, and particulate matter (PM) across the world are pushing the prevalence and intensity of allergies. In 2020, according to the World Allergy Organization (WAO), allergic rhinitis was one of the most prevalent allergies, affecting 400 million people globally.

Preference for Antihistamine Medication Due to Immediate Relief and Easy Availability

In terms of treatment, the antihistamines segment is projected to dominate the market and account for 50% share by 2031. Antihistamines are the first line of treatment in case of pet allergies. They are cost-effective, easily available, and provide immediate relief. Antihistamines treat allergy symptoms such as nasal congestion, runny nose, sneezing, or itching, nasal passage enlargement, hives, and other skin rashes, and itchy, runny eyes. Treating these symptoms can help the patient feel better during the day and sleep better at night. The antihistamine dosage is determined by the allergy symptoms.

Increase in Prevalence of Allergic Rhinitis to Lead Global Cat Allergy in Humans Market

Based on application, the allergy treatment segment accounted for a major share of 95% of the global market in 2021. Easy availability and low cost of anti-allergy drugs are expected to drive the segment during the forecast period. The growth of the segment is due to rise in prevalence of allergic rhinitis and the expansion of government-funded healthcare programmes to raise awareness about cat litter allergy in humans. Increasing pollution levels around the world as well as distinct genetic changes are driving the allergy treatment segment. Moreover, increase in adoption of immunotherapy to treat pet allergy conditions, owing to good efficacy of therapy is expected to propel the segment over the next few years.

Regional Outlook of Global Cat Allergy in Humans Market

North America dominated the global cat allergy in humans market in 2021. The market in the region is anticipated to grow at a CAGR of 6.1% from 2022 to 2031. The growth of the market in North America can be attributed to high prevalence of cat allergy in humans and increase in pet cat population.

According to the American Academy of Allergy, Asthma, and Immunology, Pet allergies (cat) affect about 15% of the U.S. population each year. In 2014, it was also reported that approximately 14% of children aged 6 to 19 were allergic to cats.

The market in Asia Pacific is estimated to grow at a notable CAGR rate during the forecast period, due to development of appropriate healthcare infrastructure and rise in awareness about progressive immunotherapy, such as allergen immunotherapy, in allergy treatment. Increase in awareness about pet Allergy is also fueling the market in Asia Pacific.

Some of the prominent players in the Cat Allergy in Humans Market include:

• Bayer AG
• Covis Pharma B.V
• HollisterStier Allergy (Jubilant Pharma, Cipla Limited
• GlaxoSmithKline plc
• Merck & Co. Inc
• Regeneron Pharmaceuticals, Inc
• Saiba Animal Health AG
• Sanofi, Stallergenes Greer.
• Other prominent players

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Cat Allergy in Humans market

• Treatment
• Antihistamines
• Corticosteroid Nasal Sprays
• Decongestants
• Leukotriene Inhibitors
• Others
• Application
• Allergy Treatment
• Allergy Prevention
• Distribution Channel
• Hospital Pharmacies
• Retail pharmacies
• Online Pharmacies

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Key Benefits for Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the global Cat Allergy in Humans industry analysis from 2022 to 2030 to identify the prevailing Cat Allergy in Humans industry opportunity.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the global Cat Allergy in Humans industry segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global Cat Allergy in Humans industry trends, key players, market segments, application areas, and market growth strategies.